Adverse Effects Electrolyte imbalance: hypokalemia, hyponatremia, hypocalcemia Dehydration and hypotension Ototoxicity (especially with rapid IV administration or with aminoglycosides) Hyperuricemia may precipitate gout Hyperglycemia (mild) Contraindications Severe electrolyte depletion (e.g., hypokalemia, hyponatremia) Anuria (no urine output) Hypersensitivity to sulfonamides (use with caution) Drug Interactions Aminoglycosides: risk of ototoxicity Digoxin: risk of digoxin toxicity due to hypokalemia NSAIDs: reduce diuretic effect Other antihypertensives: additive hypotensive effects Key Counseling Points Take in the morning to avoid nighttime urination
This view was the dominant one, and it has been codified into public health policies, treatment access, and research
Improved Metabolic Health : Tirzepatide can lower blood pressure, improve insulin sensitivity, & minimize the risk of chronic diseases
However, it is worth understanding the difference between 503A and 503B compounding pharmacies
The bellwether trial process where select representative cases go to trial first is expected to inform settlement negotiations
Using two GLP-1 agonists simultaneously is medically contraindicated and dangerous